148 related articles for article (PubMed ID: 34564931)
1. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis.
Altshuler PJ; Dang H; Frank AM; Shah AP; Glorioso J; Zhan T; Rios Diaz A; Shaheen O; Ramirez CB; Maley WR; Bodzin AS
Liver Transpl; 2022 Apr; 28(4):623-635. PubMed ID: 34564931
[TBL] [Abstract][Full Text] [Related]
2. Hepatic macrosteatosis in the US pediatric deceased liver donor population.
Purvis JW; Orandi BJ; Dhall D; McLeod C; Gutierrez Sanchez LH; Gray M; Frey K; Sheikh SS; Cannon RM; Terrault NA; Lewis CE; Locke JE
Pediatr Transplant; 2022 Feb; 26(1):e14155. PubMed ID: 34590386
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
[TBL] [Abstract][Full Text] [Related]
4. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.
Alvikas J; Deeb AP; Jorgensen DR; Minervini MI; Demetris AJ; Lemon K; Chen X; Labiner H; Malik S; Hughes C; Humar A; Tevar A
Transplant Proc; 2021 Jun; 53(5):1682-1689. PubMed ID: 33931249
[TBL] [Abstract][Full Text] [Related]
5. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ
Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675
[TBL] [Abstract][Full Text] [Related]
6. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
9. Steatosis in Liver Transplantation: Current Limitations and Future Strategies.
Linares I; Hamar M; Selzner N; Selzner M
Transplantation; 2019 Jan; 103(1):78-90. PubMed ID: 30418431
[TBL] [Abstract][Full Text] [Related]
10. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation.
Núñez K; Hamed M; Fort D; Bruce D; Thevenot P; Cohen A
World J Transplant; 2020 May; 10(5):117-128. PubMed ID: 32864357
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
[TBL] [Abstract][Full Text] [Related]
12. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.
Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB
Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923
[TBL] [Abstract][Full Text] [Related]
13. Regional Variation in Utilization and Outcomes of Liver Allografts From Donors With High Body Mass Index and Graft Macrosteatosis: A Role for Liver Biopsy.
Steggerda JA; Kim IK; Malinoski D; Klein AS; Bloom MB
Transplantation; 2019 Jan; 103(1):122-130. PubMed ID: 30048394
[TBL] [Abstract][Full Text] [Related]
14. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of greater graft failure risk of female-to-male liver transplantation with donors older than 40 years or graft macrosteatosis greater than 5.
Han S; Kwon JH; Lee KW; Lee S; Choi GS; Kim JM; Ko JS; Gwak MS; Kim GS; Ha SY; Joh JW
Sci Rep; 2023 Aug; 13(1):12914. PubMed ID: 37558742
[TBL] [Abstract][Full Text] [Related]
16. Outcome for Pediatric Recipients of Macrosteatotic Liver Grafts From Living Donors.
Irie R; Nakazawa A; Sakamoto S; Takeda M; Yanagi Y; Shimizu S; Uchida H; Fukuda A; Kasahara M
Liver Transpl; 2020 Jul; 26(7):899-905. PubMed ID: 32314485
[TBL] [Abstract][Full Text] [Related]
17. Sequential Protocol Biopsies Post-Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat?
Croome KP; Livingston D; Croome S; Keaveny AP; Taner CB; Nakhleh R
Liver Transpl; 2021 Feb; 27(2):248-256. PubMed ID: 32779325
[TBL] [Abstract][Full Text] [Related]
18. Utilizing Macrosteatotic Allografts for Nonalcoholic Steatohepatitis Recipients.
Brubaker AL; Loomba R
Liver Transpl; 2022 Apr; 28(4):552-553. PubMed ID: 34806817
[No Abstract] [Full Text] [Related]
19. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
20. Octogenarian liver grafts: Is their use for transplant currently justified?
Jiménez-Romero C; Cambra F; Caso O; Manrique A; Calvo J; Marcacuzco A; Rioja P; Lora D; Justo I
World J Gastroenterol; 2017 May; 23(17):3099-3110. PubMed ID: 28533667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
